184 related articles for article (PubMed ID: 36653507)
21. microRNA-378a-3p regulates the progression of hepatocellular carcinoma by regulating PD-L1 and STAT3.
Li Y; Zhou T; Cheng X; Li D; Zhao M; Zheng WV
Bioengineered; 2022 Mar; 13(3):4730-4743. PubMed ID: 35184646
[TBL] [Abstract][Full Text] [Related]
22. miR-194-5p down-regulates tumor cell PD-L1 expression and promotes anti-tumor immunity in pancreatic cancer.
Wang C; Li X; Zhang L; Chen Y; Dong R; Zhang J; Zhao J; Guo X; Yang G; Li Y; Gu C; Xi Q; Zhang R
Int Immunopharmacol; 2021 Aug; 97():107822. PubMed ID: 34098485
[TBL] [Abstract][Full Text] [Related]
23. Endoplasmic reticulum stress-induced exosomal miR-27a-3p promotes immune escape in breast cancer via regulating PD-L1 expression in macrophages.
Yao X; Tu Y; Xu Y; Guo Y; Yao F; Zhang X
J Cell Mol Med; 2020 Sep; 24(17):9560-9573. PubMed ID: 32672418
[TBL] [Abstract][Full Text] [Related]
24. MicroRNA-596 acts as a tumor suppressor in gastric cancer and is upregulated by promotor demethylation.
Zhang Z; Dai DQ
World J Gastroenterol; 2019 Mar; 25(10):1224-1237. PubMed ID: 30886505
[TBL] [Abstract][Full Text] [Related]
25. LINC00657 activates PD-L1 to promote osteosarcoma metastasis via miR-106a.
Zhang J; Chou X; Zhuang M; Zhu C; Hu Y; Cheng D; Liu Z
J Cell Biochem; 2020 Oct; 121(10):4188-4195. PubMed ID: 31898338
[TBL] [Abstract][Full Text] [Related]
26. MiR-214 prevents the progression of diffuse large B-cell lymphoma by targeting PD-L1.
Sun JR; Zhang X; Zhang Y
Cell Mol Biol Lett; 2019; 24():68. PubMed ID: 31844419
[TBL] [Abstract][Full Text] [Related]
27. [Plasma exosomal miR-335-5p serves as a diagnostic indicator and inhibits immune escape in triple-negative breast cancer].
Chen T; Dong Y; Wu X
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi; 2022 Apr; 38(4):347-356. PubMed ID: 35583065
[TBL] [Abstract][Full Text] [Related]
28. Yin Yang 1-stimulated long noncoding RNA bladder cancer-associated transcript 1 upregulation facilitates esophageal carcinoma progression via the microRNA-5590-3p/programmed cell death-ligand 1 pathway.
Cheng J; Yang Q; Han X; Wang H; Wu K; Zhao H
Bioengineered; 2022 Apr; 13(4):10244-10257. PubMed ID: 35435118
[TBL] [Abstract][Full Text] [Related]
29. MicroRNA-375 reverses the expression of PD-L1 by inactivating the JAK2/STAT3 signaling pathways in gastric cancer.
Yan XL; Luo QY; Zhou SN; Pan WT; Zhang L; Yang DJ; Qiu MZ
Clin Res Hepatol Gastroenterol; 2021 Sep; 45(5):101574. PubMed ID: 33272890
[TBL] [Abstract][Full Text] [Related]
30. miRNA-148a-3p Regulates Immunosuppression in DNA Mismatch Repair-Deficient Colorectal Cancer by Targeting PD-L1.
Ashizawa M; Okayama H; Ishigame T; Thar Min AK; Saito K; Ujiie D; Murakami Y; Kikuchi T; Nakayama Y; Noda M; Tada T; Endo H; Fujita S; Sakamoto W; Saito M; Saze Z; Momma T; Ohki S; Mimura K; Kono K
Mol Cancer Res; 2019 Jun; 17(6):1403-1413. PubMed ID: 30872332
[TBL] [Abstract][Full Text] [Related]
31. MicroRNA-497-5p down-regulation increases PD-L1 expression in clear cell renal cell carcinoma.
Qu F; Ye J; Pan X; Wang J; Gan S; Chu C; Chu J; Zhang X; Liu M; He H; Cui X
J Drug Target; 2019 Jan; 27(1):67-74. PubMed ID: 30183478
[TBL] [Abstract][Full Text] [Related]
32. Cisplatin-mediated down-regulation of miR-145 contributes to up-regulation of PD-L1 via the c-Myc transcription factor in cisplatin-resistant ovarian carcinoma cells.
Sheng Q; Zhang Y; Wang Z; Ding J; Song Y; Zhao W
Clin Exp Immunol; 2020 Apr; 200(1):45-52. PubMed ID: 31821542
[TBL] [Abstract][Full Text] [Related]
33. Cancer-Associated Fibroblasts-Derived Exosomes Suppress Immune Cell Function in Breast Cancer via the miR-92/PD-L1 Pathway.
Dou D; Ren X; Han M; Xu X; Ge X; Gu Y; Wang X
Front Immunol; 2020; 11():2026. PubMed ID: 33162971
[TBL] [Abstract][Full Text] [Related]
34. miR-142-5p regulates CD4+ T cells in human non-small cell lung cancer through PD-L1 expression via the PTEN pathway.
Wan J; Ling X; Peng B; Ding G
Oncol Rep; 2018 Jul; 40(1):272-282. PubMed ID: 29767245
[TBL] [Abstract][Full Text] [Related]
35. HOXA-AS3 Promotes Proliferation and Migration of Hepatocellular Carcinoma Cells via the miR-455-5p/PD-L1 Axis.
Zeng C; Ye S; Chen Y; Zhang Q; Luo Y; Gai L; Luo B
J Immunol Res; 2021; 2021():9289719. PubMed ID: 34988230
[TBL] [Abstract][Full Text] [Related]
36. CircFOXK2 enhances tumorigenesis and immune evasion in non-small cell lung cancer by miR-485-5p/PD-L1 axis.
Zhang N; Fan J; Deng Z
Anticancer Drugs; 2022 Jun; 33(5):437-447. PubMed ID: 35324518
[TBL] [Abstract][Full Text] [Related]
37. LncRNA LINC00184 promotes docetaxel resistance and immune escape via miR-105-5p/PD-L1 axis in prostate cancer.
Zhang W; Xin J; Lai J; Zhang W
Immunobiology; 2022 Jan; 227(1):152163. PubMed ID: 34896914
[TBL] [Abstract][Full Text] [Related]
38. MiR-10b-5p Impairs TET2-Mediated Inhibition of PD-L1 Transcription Thus Promoting Immune Evasion and Tumor Progression in Glioblastoma.
Du W; Chen D; Wei K; Yu D; Gan Z; Xu G; Yao G
Tohoku J Exp Med; 2023 Jul; 260(3):205-214. PubMed ID: 37019647
[TBL] [Abstract][Full Text] [Related]
39. Downregulation of miR-129-2 by promoter hypermethylation regulates breast cancer cell proliferation and apoptosis.
Tang X; Tang J; Liu X; Zeng L; Cheng C; Luo Y; Li L; Qin SL; Sang Y; Deng LM; Lv XB
Oncol Rep; 2016 May; 35(5):2963-9. PubMed ID: 26935022
[TBL] [Abstract][Full Text] [Related]
40. Circular RNA hsa_circ_0043278 inhibits breast cancer progression via the miR-455-3p/EI24 signalling pathway.
Shi Y; Liu C
BMC Cancer; 2021 Nov; 21(1):1249. PubMed ID: 34800978
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
